[HTML][HTML] Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular …

S Roy, C Coldren, A Karunamurthy, NS Kip… - The Journal of Molecular …, 2018 - Elsevier
Bioinformatics pipelines are an integral component of next-generation sequencing (NGS).
Processing raw sequence data to detect genomic alterations has significant impact on …

[HTML][HTML] Chronic granulomatous disease

D Roos - British medical bulletin, 2016 - ncbi.nlm.nih.gov
Introduction: Chronic granulomatous disease (CGD) is a primary immunodeficiency
characterized by recurrent, life-threatening bacterial and fungal infections of the skin, the …

[HTML][HTML] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation …

DT Cheng, TN Mitchell, A Zehir, RH Shah… - The Journal of molecular …, 2015 - Elsevier
The identification of specific genetic alterations as key oncogenic drivers and the
development of targeted therapies are together transforming clinical oncology and creating …

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications

CR Churi, R Shroff, Y Wang, A Rashid, HSC Kang… - PloS one, 2014 - journals.plos.org
Background Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic
CCA have diverse clinical presentations. Next generation sequencing (NGS) technology …

HER2/neu-directed therapy for biliary tract cancer

M Javle, C Churi, HSC Kang, R Shroff, F Janku… - Journal of hematology & …, 2015 - Springer
Background Biliary cancers are highly aggressive tumors that are often diagnosed an
advanced disease stage and have a poor outcome with systemic therapy. Recent efforts …

Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in …

RK Basho, M Gilcrease, RK Murthy, T Helgason… - JAMA …, 2017 - jamanetwork.com
Importance Triple-negative breast cancer (TNBC) classified by transcriptional profiling as the
mesenchymal subtype frequently harbors aberrations in the phosphoinositide 3-kinase …

Neoadjuvant BRAF-and immune-directed therapy for anaplastic thyroid carcinoma

ME Cabanillas, R Ferrarotto, AS Garden, S Ahmed… - Thyroid, 2018 - liebertpub.com
Anaplastic thyroid cancer (ATC) is a devastating disease with a dismal prognosis. Patients
who have disease confined to the thyroid and who are able to undergo complete surgery …

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

CT Hiley, J Le Quesne, G Santis, R Sharpe… - The Lancet, 2016 - thelancet.com
Lung cancer diagnostics have progressed greatly in the previous decade. Development of
molecular testing to identify an increasing number of potentially clinically actionable genetic …

Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma

JR Wang, M Montierth, L Xu, M Goswami… - JCO Precision …, 2022 - ascopubs.org
PURPOSE Anaplastic thyroid carcinoma (ATC) uniformly present with aggressive disease,
but the mutational landscape of tumors varies. We aimed to determine whether tumor …

Expert opinion on NSCLC small specimen biomarker testing—Part 1: Tissue collection and management

F Penault-Llorca, KM Kerr, P Garrido, E Thunnissen… - Virchows Archiv, 2022 - Springer
Biomarker testing is crucial for treatment selection in advanced non-small cell lung cancer
(NSCLC). However, the quantity of available tissue often presents a key constraint for …